Resum
Based on a computational model for 5-HT1AR-ligand interaction and QSAR studies, we have designed and synthesized a new series of arylpiperazines 2-8 which exhibit high 5-HT1AR affinity and selectivity over α1-adrenergic receptors. Among them, compound CSP-2503 (4) has been pharmacologically characterized as a 5-HT1AR agonist at somatodendritic and postsynaptic sites, endowed with anxiolytic properties. © 2003 Elsevier Science Ltd. All rights reserved.
Idioma original | Anglès |
---|---|
Pàgines (de-a) | 1429-1432 |
Revista | Bioorganic and Medicinal Chemistry Letters |
Volum | 13 |
Número | 8 |
DOIs | |
Estat de la publicació | Publicada - 17 d’abr. 2003 |